Fundraising FoxAtria Ventures — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
Peer AI builds AI-powered tools for drug development and clinical research, with a focus on medical writing and regulatory work.
AI & Machine LearningBiotechDigital HealthSaaS
Anita Modi(Co-Founder & CEO)inChris Ceppi(Co-Founder, CTO & COO)Ravi Ramachandran(Co-Founder & Chief Scientific and Regulatory Officer)in
PartnerChris Leiter· solo GP
Co-investorsAlumni VenturesFlare Capital PartnersGaingelsGreycroftMana VenturesSignalFire
__Twitter.png)
Sleuth provides evidence-backed answers for biopharma decision-making, built on a knowledge graph that maps over a billion relationships across biology, clinical evidence, competitive dynamics, and deal history.
AI & Machine LearningBiotechData & InfrastructureFintechSan Francisco, US
Andrew Pannu(Executive Officer, Director)
BoardCaleb Appleton(Director)inMark Jacobstein(Director)
PartnerChris Leiter· solo GP
Co-investorsBison VenturesHAWKTAIL
Trially uses AI and data science to match patients with clinical trials and accelerate trial recruitment.
AI & Machine LearningDigital HealthHealthtechMedical DevicesKansas City, US
Kyle McAllister(CEO & Founder)inTrevor Welch(Executive Officer, Director)in
BoardThad Langford(Director)in
Co-investorsAlpaca VCCorigin VenturesFlyover CapitalGaingelsRedbud VCThe Council+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.